
    
      The purpose of this clinical trial is to collect safety and effectiveness data to support
      cardiac repair indication of XenoSure biologic patch. This trial is performed to meet the
      China FDA regulations for this kind of device. The clinical trial will be performed solely
      inside China under GCP regulation and all applicable China regulations on medical device
      clinical trial.

      There will be 144 subjects enrolled, including 72 subjects in the trial arm and 72 subjects
      in the control arm.
    
  